Earnings Labs
KalVista Pharmaceuticals, Inc. logo

KalVista Pharmaceuticals, Inc. (KALV) Earnings Call Transcripts

NASDAQ·Healthcare·Biotechnology

$19.19

+0.16%

Mkt Cap $977.33M

All KALV earnings call transcripts, listed in reverse chronological order. Earnings Labs publishes the complete transcript of every KALV earnings call — free, no signup, with AI-generated summaries and key takeaways.